Stemtech Corporation (OTCQB;STEK), a leader in the development and distribution of stemceutical™ products for humans offered since 2005, is proud to announce an exciting new product line into the pet health care industry with the launch of “StemPets™.”
This revolutionary product is designed to provide substantial health benefits to dogs, cats, and other beloved pets, tapping into the $303 billion pet health care market.
Recognizing the profound love humans hold for their pets and the significant expenses they incur to keep them healthy, Stemtech has developed StemPets. This natural stemceutical product promises to offer amazing health benefits to pets as our human products have provided for nearly two decades.
“We are thrilled to introduce StemPets to the market,” said Charles S. Arnold”, Chairman & CEO of Stemtech.
He goes on to say that
“pet owners go to great lengths to ensure the well-being of their animals, and StemPets offers a natural solution that supports their health. Our product is not only beneficial for pet health, but is also appealing to them, as animals find the natural flavor pleasant without the need for artificial flavoring. My eight-year-old dog Plato has more energy and vitality since taking StemPets.”
John W. Meyer, President & COO states
“the new StemPets